Steven K - Search Results

1

[Interleukin-2 based immunotherapy of cancer].

Geertsen PF, Hermann GG, Claësson MH, Steven K, Zeuthen J, von der Maase H. Geertsen PF, et al. Among authors: steven k. Ugeskr Laeger. 1990 Nov 19;152(47):3513-7. Ugeskr Laeger. 1990. PMID: 2256204 Review. Danish.

2

Treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2: a single-center phase II study.

Geertsen PF, Hermann GG, von der Maase H, Steven K. Geertsen PF, et al. Among authors: steven k. J Clin Oncol. 1992 May;10(5):753-9. doi: 10.1200/JCO.1992.10.5.753. J Clin Oncol. 1992. PMID: 1569448 Clinical Trial.

3

[Urinary bladder cancer].

von der Maase H, Steven K. von der Maase H, et al. Among authors: steven k. Ugeskr Laeger. 2002 Jun 3;164(23):3052-6. Ugeskr Laeger. 2002. PMID: 12082860 Danish. No abstract available.

4

Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects.

Hermann GG, Geertsen PF, von der Maase H, Steven K, Andersen C, Hald T, Zeuthen J. Hermann GG, et al. Among authors: steven k. Cancer Res. 1992 Feb 1;52(3):726-33. Cancer Res. 1992. PMID: 1732060

5

The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer.

Hermann GG, Horn T, Steven K. Hermann GG, et al. Among authors: steven k. J Urol. 1998 Jan;159(1):91-4. doi: 10.1016/s0022-5347(01)64021-7. J Urol. 1998. PMID: 9400444

6

Low dose intravesical heparin as prophylaxis against recurrent noninvasive (stage Ta) bladder cancer.

Bitsch M, Hermann GG, Andersen JP, Steven K. Bitsch M, et al. Among authors: steven k. J Urol. 1990 Sep;144(3):635-6. doi: 10.1016/s0022-5347(17)39542-3. J Urol. 1990. PMID: 2201794 Clinical Trial.

7

Intravesical BCG therapy in bladder carcinoma. Effect on cytotoxicity, IL-2 production and phenotype of peripheral blood mononuclear cells.

Hermann GG, Petersen KR, Zeuthen J, Steven K. Hermann GG, et al. Among authors: steven k. Scand J Urol Nephrol. 1991;25(4):269-73. doi: 10.3109/00365599109024557. Scand J Urol Nephrol. 1991. PMID: 1780700

8

Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.

Hermann GG, Petersen KR, Steven K, Zeuthen J. Hermann GG, et al. Among authors: steven k. J Clin Immunol. 1990 Nov;10(6):311-20. doi: 10.1007/BF00917476. J Clin Immunol. 1990. PMID: 1707414

9

The in vitro cytotoxicity of urine from patients with interstitial cystitis.

Beier-Holgersen R, Hermann GG, Mortensen SO, Steven K. Beier-Holgersen R, et al. Among authors: steven k. J Urol. 1994 Jan;151(1):206-7. doi: 10.1016/s0022-5347(17)34917-0. J Urol. 1994. PMID: 8254814

10

Voiding patterns and prevalence of incontinence in women. A questionnaire survey.

Sommer P, Bauer T, Nielsen KK, Kristensen ES, Hermann GG, Steven K, Nordling J. Sommer P, et al. Among authors: steven k. Br J Urol. 1990 Jul;66(1):12-5. doi: 10.1111/j.1464-410x.1990.tb14855.x. Br J Urol. 1990. PMID: 2393793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters